SEC 13F Intelligence

York Capital Management Global Advisors, LLC / BMRN

York Capital Management Global Advisors, LLC’s Biomarin Pharmaceutical Inc Position

Does York Capital Management Global Advisors, LLC own Biomarin Pharmaceutical Inc (BMRN)? Not currently — the last reported position was 748.4K shares worth $50M in Q3 2019; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$50M
Q3 2019
Shares
748.4K
% of Portfolio
+2.34%
Quarters Held
2
position exited

Position History BMRN

Reported value by quarter
Q2 ’19: $96MQ2 ’19Q3 ’19: $50MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2019748.4K$50M+2.34%
Q2 20191.12M$96M+3.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See York Capital Management Global Advisors, LLC’s full portfolio or all institutional holders of BMRN.